Neurofeedback for Post-Concussion Syndrome
(NFBVETmTBI Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if neurofeedback (NFB) can assist veterans with mild traumatic brain injury (mTBI) who suffer from chronic headaches, sleep issues, and attention problems. NFB is a safe, computer-based training that enhances brain function by providing real-time feedback. The trial divides participants into two groups: one will receive NFB sessions, while the other will continue usual care with weekly health calls and later receive NFB. Veterans experiencing chronic headaches, sleep troubles, and attention difficulties due to mTBI might find this trial suitable. As an unphased trial, it offers veterans the chance to explore a potentially beneficial treatment for mTBI-related issues.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that neurofeedback is safe for treating post-concussion syndrome?
Research has shown that neurofeedback (NFB) is a safe treatment for individuals with post-concussion symptoms. Studies indicate that it is non-invasive, meaning it doesn't involve surgery or entering the body. One study found that NFB reduced long-lasting headaches, sleep problems, and attention issues without causing harm. Another study demonstrated improvements in emotional control, sleep, and relationships, with no major side effects reported. Overall, NFB is well-tolerated, and the risks are low, making it a promising option for safely managing concussion-related symptoms.12345
Why are researchers excited about this trial?
Neurofeedback (NFB) is unique because it directly targets physiological dysregulation by training the brain to function more effectively. Unlike standard treatments for post-concussion syndrome, which often include medication and cognitive therapy, NFB offers a non-invasive approach that involves real-time feedback on brain wave patterns. This allows participants to actively engage in their own recovery process by learning to achieve a focused, relaxed state, potentially enhancing overall brain function. Researchers are excited about this treatment because it offers a novel way to address the underlying issues of post-concussion symptoms, rather than just managing them.
What evidence suggests that neurofeedback might be an effective treatment for post-concussion syndrome?
Research shows that neurofeedback (NFB), which participants in this trial may receive, could be a promising treatment for post-concussion symptoms such as long-lasting headaches, sleep problems, and trouble focusing. Studies have found that a type of NFB called infra-low frequency neurofeedback helps the brain heal and manage itself after head injuries. This method trains the brain to change its activity, which can improve symptoms. While some research suggests NFB might not aid in stress reduction, it has proven useful for anxiety, PTSD, and OCD, conditions often linked to post-concussion syndrome. Overall, early evidence supports its potential benefits for those with post-concussion symptoms.12456
Who Is on the Research Team?
Judy M Carlson, EdD
Principal Investigator
VA Pacific Islands Health Care System, Honolulu, HI
Are You a Good Fit for This Trial?
This trial is for male and non-pregnant female Veterans aged 18 to 65 who served in OEF-OIF-OND, have mild traumatic brain injury (mTBI), and suffer from chronic headaches, insomnia, or attention difficulties. Participants must be able to understand instructions, read and write English. Those with severe TBI, unable to attend study visits, pregnant women, individuals with impaired decision-making capacity or suicidal intent are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive neurofeedback training up to 5 times a week, usually 3 times a week, for a total of 20 sessions over 8-10 weeks.
Control Group Activities
Participants in the control group receive usual care and weekly 15-minute calls on health topics for 8 weeks.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 2-month follow-up.
What Are the Treatments Tested in This Trial?
Interventions
- Neurofeedback (NFB)
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor